Elvir Becirovic has been a group leader at the Department of Pharmacy of the LMU and was recently appointed as Professor of Experimental and Translational Ophthalmology at the University of Zurich. His group is developing innovative gene therapy and gene editing technologies, for example, to expand the size limit of AAV vectors.